(Q43678414)

25 November 2017

Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system (English)

1 reference

25 November 2017

0 references

0 references

D Braida

1

1 reference

25 November 2017

M Pozzi

series ordinal

2

1 reference

25 November 2017

R Cavallini

series ordinal

3

1 reference

25 November 2017

M Sala

series ordinal

4

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

25 November 2017

1 reference

25 November 2017

104

1 reference

25 November 2017

923-926

1 reference

25 November 2017

4

1 reference

Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Cannabinoid receptors and reward in the rat: a conditioned place preference study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Opioid and cannabinoid receptor inhibition of adenylyl cyclase in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Pharmacologic characterization of nicotine-induced conditioned place preference.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Cannabinoid transmission and reward-related events.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Synergistic efects of opioid and cannabinoid antagonists on food intake

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Aversive effects of the synthetic cannabinoid CP 55,940 in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Dose-dependent conditioned place preference produced by etonitazene and morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Endogenous cannabinoids as an aversive or counter-rewarding system in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

THC-induced place and taste aversions in Lewis and Sprague-Dawley rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900210-X

7 January 2021

10.1016/S0306-4522(01)00210-X

Identifiers

DOI

1 reference

25 November 2017

1 reference